Suicidality risk after using cannabis and cannabinoids: An umbrella review

Abstract The increasing prevalence and burden of suicide have led to numerous studies to identify its risk factors. Cannabis is the most common illicit substance

November 29, 2023

Suicidal Ideation in Medicinal Cannabis Patients: A 12-Month Prospective Study

Please use this link to access this publication. Abstract Objective To document the prevalence and correlates of suicidal ideation (SI) among individuals seeking cannabis-based medicinal

April 17, 2025

Substitution of medical cannabis for pharmaceutical agents for pain, anxiety, and sleep

Please use this link to access this publication. Abstract A prior epidemiological study identified a reduction in opioid overdose deaths in US states that legalized

October 3, 2024

Substituting cannabis for prescription drugs, alcohol and other substances among medical cannabis patients: The impact of contextual factors

Please use this link to access this publication. Abstract Introduction and Aims Recent years have witnessed increased attention to how cannabis use impacts the use

Substituting Cannabidiol for Opioids and Pain Medications Among Individuals With Fibromyalgia: A Large Online Survey

Abstract People report substituting cannabis for pain medications, but whether cannabidiol (CBD) is used similarly remains unknown. CBD products can be CBD alone (isolate), hemp

April 16, 2024

Substance use and use disorders during pregnancy and the postpartum period

Please use this link to access this publication. Abstract Substance use and substance use disorders among pregnant and postpartum individuals have risen dramatically, necessitating enhanced

May 2, 2026

Subjective, behavioral and neurobiological effects of cannabis and cannabinoids in social anxiety

Please use this link to access this publication: https://www.degruyter.com/document/doi/10.1515/revneuro-2023-0078/html Abstract Social anxiety disorder (SAD) is a debilitating disorder, characterized by fear and anxiety in social situations.

November 30, 2023

Subjective and physiological effects after controlled Sativex and oral THC administration

Abstract Sativex is a cannabis-plant extract delivering nearly 1:1 Δ(9)-tetrahydrocannabinol (THC) and cannabidiol (CBD) by oromucosal spray. It has been suggested that CBD attenuates THC-induced

November 16, 2023

Subanalyses concerning “Differential impact of Cannabis abuse on neurological disorders

Please use this link to access this publication.  

February 7, 2026

Subacute cannabidiol alters genome-wide DNA methylation in adult mouse hippocampus

Please use this link to access this publication. Abstract Use of cannabidiol (CBD), the most abundant non-psychoactive compound found in cannabis (Cannabis sativa), has recently

July 2, 2024